Welcome to our dedicated page for BDR news (Ticker: BDR), a resource for investors and traders seeking the latest updates and insights on BDR stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BDR's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BDR's position in the market.
Blonder Tongue Laboratories (NYSE American: BDR) announced it has received a notice from NYSE American regarding noncompliance with listing standards. The company reported stockholders' equity of $2,614,000 and has incurred losses in all its recent fiscal years. An earlier plan to regain compliance was accepted, extending the deadline to December 10, 2021. The company has struggled with compliance due to COVID-19 impacts and is at risk of delisting if not compliant by the deadline. The notice does not currently affect its business operations.
Blonder Tongue Laboratories reported a 21.0% decrease in net sales, totaling $4.17 million for Q3 2020, down from $5.28 million in Q3 2019. The net loss for the quarter was $(1.79 million) or $(0.18) per diluted share, compared to $(1.33 million) or $(0.14) per diluted share in the previous year. For the nine months ending September 30, 2020, net sales fell 18.6% to $12.05 million. This decline is attributed to decreased sales in digital video headend and DOCSIS data products, despite gains in transcoder products.
Blonder Tongue Laboratories, Inc. (NYSE American: BDR) has rescheduled its Q3 2020 earnings results announcement to November 11, 2020, before market opening. A teleconference will follow at 11:00 a.m. ET, where management will discuss the financial results. This change replaces the previously scheduled date of November 13, 2020. Investors can participate by dialing 844-602-0380 (toll-free in US & Canada). The company is recognized as a leader in cable TV video transmission technology, emphasizing US-based manufacturing and engineering excellence.
Blonder Tongue Laboratories, Inc. (NYSE American: BDR) is set to announce its Third Quarter 2020 Earnings Results on November 13, 2020, before market opening. A live teleconference to discuss these results will follow at 11:00 a.m. ET. Investors can dial in toll-free at 844-602-0380. The company is recognized for its expertise in cable television video transmission technology and has been operational for over 50 years in New Jersey.
OLD BRIDGE, NJ / ACCESSWIRE / October 13, 2020: Blonder Tongue Laboratories (NYSE American: BDR) announced that the US Patent and Trademark Office granted patent US10,805,660 for their DOCSIS Data (DMM) series products. These products are designed to simultaneously deliver traditional live TV, on-demand OTT services, and telephony solutions. The patented technology offers a modular approach for enhanced service delivery, allowing for seamless upgrades from wireline to wireless. The company emphasizes its 50-year legacy in cable video transmission technology.
Blonder Tongue Laboratories (NYSE American: BDR) announced that the USPTO granted patent US10,785,829 for its NeXgen Gateway (NXG) video delivery platform. This technology enhances migration from traditional video delivery systems to IP-based architectures, supporting various service providers in efficiently managing video content delivery across multiple sectors, including hospitality and healthcare. The NXG platform’s modular design allows for ongoing adaptations without major infrastructure overhauls, highlighting its versatility and long-term utility in evolving digital landscapes.
Blonder Tongue Laboratories, Inc. (NYSE American: BDR) has received notification from NYSE Regulation regarding the acceptance of its compliance plan to meet NYSE American's listing standards, specifically Section 1003(a)(iii). The company previously reported stockholders' equity of $5.4 million and has incurred losses over the last five fiscal years, leading to the necessity for a plan submission by July 10, 2020. The accepted plan provides a timeframe until December 10, 2021, for compliance; however, there are no guarantees that the company will meet these requirements in time.
OLD BRIDGE, NJ / ACCESSWIRE / August 19, 2020: Blonder Tongue Laboratories, Inc. (NYSE American: BDR) has addressed the recent surge in its stock's trading activity, noting no known reasons for the increase in price or volume. The company stated there have been no material changes regarding its business since its second-quarter earnings release on August 7, 2020. Blonder Tongue, a leader in cable television technology, continues to focus on delivering high-reliability digital video and broadband services.
Blonder Tongue Laboratories, Inc. (NYSE American:BDR) has appointed Rick Briggs to its Board of Directors. With over 30 years of experience in the senior living technology sector, Mr. Briggs founded Stellar Private Cable, the first private-network TV provider for long-term care. His expertise includes satellite and cable systems, which align with Blonder Tongue's services. The management believes his background will benefit the company in product design and market penetration amid current challenges.
Blonder Tongue Laboratories, Inc. (NYSE American:BDR) has appointed Rick Briggs to its Board of Directors. Briggs brings over 30 years of experience in technology solutions for senior living, having founded SeniorTV, a leading private-network TV provider. Following the sale of SeniorTV to Sentrics, where he served as CMO, Briggs now joins Blonder Tongue to enhance its strategic direction and product development. His background in cable and internet services aligns closely with the company’s focus on digital solutions for senior living and related sectors.
FAQ
What is the market cap of BDR (BDR)?
